Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female sprague-dawley rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 3, 2006, Pages 1195-1201

  Peckham, Elizabeth M ^a   Traynor, John R ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; DIAMORPHINE; FENTANYL; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; MORPHINE DERIVATIVE; MU OPIATE RECEPTOR; OPIATE; OXYCODONE; OXYMORPHONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; FEMALE; GLIOMA CELL; GLUCURONIDATION; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; STRUCTURE ACTIVITY RELATION; TAIL FLICK TEST; THALAMUS;

ANALGESICS, OPIOID; ANIMALS; CHO CELLS; CRICETINAE; DIPRENORPHINE; FEMALE; GLUCURONOSYLTRANSFERASE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MALE; MORPHINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SEX CHARACTERISTICS; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33644756719     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.094276     Document Type: Article

References (33)

1. Anderson GD (2002) Sex differences in drug metabolism: cytochrome P-450 and uridine diphosphate glucuronosyltransferase. J Gend Specif Med 5:25-33.
2. Baker L and Ratka A (2002) Sex-specific differences in levels of morphine, morphine-3-glucuronide and morphine antinociception in rats. Pain 95:65-74.
3. Banerjee P, Chatterjee TK, and Ghosh JJ (1983) Ovarian steroids and modulation of morphine-induced analgesia and catalepsy in female rats. Eur J Pharmacol 96:291-294.
4. Bartok RE and Craft RE (1997) Sex differences in opioid antinociception. J Pharmacol Exp Ther 282:769-778.
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
6. Cepeda MS and Carr DB (2003) Women experience more pain and require more morphine than men to achieve a similar degree of analgesia. Anesth Analg 97:1464-1468.
7. Cicero TJ, Nock B, and Meyer ER (1996) Gender-related differences in the antinociceptive properties of morphine. J Pharmacol Exp Ther 279:767-773.
8. Cicero TJ, Nock B, and Meyer ER (1997) Sex-related differences in morphine's antinociceptive activity: relationship to serum and brain morphine concentrations. J Pharmacol Exp Ther 282:939-944.
9. Cleary J, Mikus G, Somogyi A, and Bochner F (1994) The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague Dawley/Dark Agouti rat model. J Pharmacol Exp Ther 271:1528-1534.
10. Coffman BL, Rios GR, King CD, and Tephly TR (1997) Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1-4.
11. Cook CD, Barrett AC, Roach EL, Bowman JR, and Picker MJ (2000) Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity and efficacy at the mu opioid receptor. Psychopharmacology 150:430-442.
12. Craft RM (2003) Sex differences in opioid analgesia: "from mouse to man". Clin J Pain 19:175-186.
13. Craft RM, Tseng A, McNiel D, Furness MS, and Rice KC (2001) Receptor-selective antagonism of opioid antinociception in male versus female rats. Behav Pharmacol 282:769-778.
14. Frances B, Gout R, Monserrat B, Cross J, and Zajac JM (1992) Further evidence that morphine-6-β -glucuronide is a more potent opioid than morphine. J Pharmacol Exp Ther 262:25-31.
15. Gong QL, Hedner T, Hedner J, Bjorkman R, and Hedner T (1992) Morphine-3-glucuronide may functionally antagonise morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain 48:249-255.
16. Green MD, King CD, Mojarrabi B, Mackenzie PI, and Tephly TR (1998) Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos 26:507-512.
17. 35S]GTPγS) binding in brain slices from Sprague-Dawley rats. J Pharmacol Exp Ther 312:1314-1320.
18. Kepler KL, Kest B, Kiefel JM, Cooper ML, and Bodnar RJ (1989) Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats. Pharmacol Biochem Behav 34:119-127.
19. Kepler KL, Standifer KM, Paul D, Kest B, Pasternak GW, and Bodnar RJ (1991) Gender effects and central opioid analgesia. Pain 45:87-94.
20. Lee KO, Akil H, Woods JH, and Traynor JR (1999) Differential binding properties of oripavines at cloned mu- and delta-opioid receptors. Eur J Pharmacol 378:323-330.
21. Mikus G, Somogyi AA, Bochner F, and Eichelbaum (1991) Codeine O-demethylation: rat strain differences and the effects of inhibitors. Biochem Pharmacol 41:757-762.
22. Miller PL and Ernst AA (2004) Sex differences in analgesia: a randomized trial of μ versus κ opioid agonists. South Med J 97:35-41.
23. Peckham EM, Barkley LM, Divin MF, Cicero TJ, and Traynor JR (2005) Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox. Brain Res 1058:137-147.
24. 35S]thiotriphosphate binding. Proc Natl Acad Sci USA 92:7242-7246.
25. Smith MT, Watt JA, and Cramond T (1990) Morphine-3-glucuronide - a potent antagonist of morphine analgesia. Life Sci 47:579-585.
26. Stoffel EC, Ulibarri CM, and Craft RM (2003) Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats. Pain 103:285-302.
27. Stoffel EC, Ulibarri CM, Folk JE, Rice KC, and Craft RM (2005) Gonadal hormone modulation of mu, kappa and delta opioid antinociception in male and female rats. J Pain 6:261-274.
28. Terner JM, Lomas LM, Smith ES, Barrett AC, and Picker MJ (2003) Pharmacogenetic analysis of sex differences in opioid antinociception in rats. Pain 106:381-391.
29. Tershner SA, Mitchell JM, and Fields HL (2000) Brainstem pain modulating circuitry is sexually dimorphic with respect to mu and kappa opioid receptor function. Pain 85:153-159.
30. Tomkins DM, Otton SV, Joharchi N, Li NY, Balster RF, Tyndale RF, and Sellers EM (1997) Effect of cytochrome P450 2D1 inhibition on hydrocodone metabolism and its behavioral consequences in rats. J Pharmacol Exp Ther 280:1374-1382.
31. Toyo'oka T, Yano M, Kato M, and Nakahara Y (2001) Simultaneous determination of morphine and its glucurondides in rat hair and plasma by reverse-phase liquid chromatography with electrospray ionization mass spectrometry. Analyst 126:1339-1345.
32. 35S]thio) trisphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47:848-854.
33. 35S] GTPγS binding to membranes: determination of potencies and efficacies of ligands. J Pharmacol Exp Ther 282:676-684.